CMR Surgical has unveiled its latest innovation, the Ultrasonic Dissector, which advances the capabilities of the Versius robotic surgical system. The new instrument utilizes ultrasonic energy for proficient tissue cutting and coagulation, enhancing the Versius Plus offerings. Versius is renowned for its accurate handling of endoscopic instruments, characterized by its compact robotic system with collaborative arms for optimal patient interaction at the bedside.
The adaptable port placement offered by Versius caters to the diverse needs of each patient, and the system supports surgeons in performing minimally invasive surgeries more efficiently. Surgeons can access organs like the lungs, thymus, and esophagus more effectively due to the system’s design, which received FDA approval in October.
By introducing the Ultrasonic Dissector, CMR Surgical presents its first advanced energy instrument that employs a unique torsional approach to deliver ultrasonic energy. This device can seal blood vessels up to 5 mm wide while maintaining a burst pressure averaging 908 mmHg, ensuring effective hemostasis with various modes to tailor to procedural demands, aiding surgeons in complex surgeries.
This development constitutes the latest addition to the Versius Plus range, which supports multi-specialty surgical procedures with a comprehensive suite of instruments, upgraded console, enhanced digital insights, and cutting-edge fluorescent imaging technology.
Mark Slack, the chief medical officer and co-founder of CMR Surgical, noted the significance of unleashing the Ultrasonic Dissector, stating, “Our collaboration with clinical partners has been pivotal in integrating this efficient ultrasonic tool with Versius. We anticipate that its multifunctional nature will provide significant benefits to surgeons, aiding them in more intricate procedures and expanding the scope of robotic-assisted minimally invasive surgeries available to their patients.”